EN
HI
Summary
As of 10 Sep, 2026, Bafna Pharmaceuticals stock price is ₹307.6. During the trading session, the stock has moved between an intraday low of ₹295.60 and an intraday high of ₹307.60. Over the last 52 weeks, Bafna Pharmaceuticals has traded between ₹94.77 and ₹318.50.
The stock has recorded a trading volume of 9,236 shares,. Its Average Traded Price (ATP) is ₹296.13, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 44 @ ₹307.60.
Bafna Pharmaceuticals has an upper circuit limit of ₹307.60 and a lower circuit limit of ₹295.60. The total value traded stands at ₹27.35 L, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Bafna Pharmaceuticals also offers a dividend yield of 0%.
Bafna Pharmaceuticals Share Price Chart
Bafna Pharmaceuticals Share Key Metrics
Volume
9236.00
Market Cap
713.48 CR
LTQ@LTP
44@307.60
ATP
296.13
Var Margin
100 %
Circuit Range
295.6-307.6
Delivery %
0 %
Value
27.35 L
ASM/GSM
No
Market Lot
1
Bafna Pharmaceuticals Resistance and Support
Pivot 302.1
Resistance
First Resistance
302.6
Second Resistance
303.6
Third Resistance
304.1
Support
First Support
301.1
Second Support
300.6
Third Support
299.6
Bafna Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Sep 10 2026 | 307.6 | 307.6 | 1.99% | 307.6 | 295.6 |
| Wed Sep 09 2026 | 301.6 | 301.6 | -2.00% | 303.1 | 301.6 |
| Tue Sep 08 2026 | 307.75 | 307.75 | 1.99% | 307.75 | 307.75 |
Bafna Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-06 | Quarterly Results |
| 2024-11-11 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Bafna Pharmaceuticals Management
| Name | Position |
|---|---|
| Shanmugam Hemalatha | Whole Time Director |
| Vinayak Dinesh Dendukuri | Whole Time Director - Quality |
Bafna Pharmaceuticals Similar Stocks
Wanbury Ltd.
241.45
-3.30 (1.35%)
Gaudium IVF and Women Health Ltd.
115.26
-1.30 (1.12%)
Anlon Healthcare Ltd.
17.54
1.26 (7.74%)
Albert David Ltd.
850.00
-0.55 (0.06%)
Hexagon Nutrition Ltd.
68.17
0.75 (1.11%)
Zim Laboratories Ltd.
136.43
3.08 (2.31%)
Osel Devices Ltd.
371.65
-1.40 (0.38%)
Influx Healthtech Ltd.
274.80
-2.80 (1.01%)
Kilitch Drugs (India) Ltd.
185.03
-3.42 (1.81%)
Bafna Pharmaceuticals FAQs
The Buying Price of Bafna Pharmaceuticals share is 307.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bafna Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bafna Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bafna Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bafna Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Bafna Pharmaceuticals’s valuation compare Sector P/E, P/B which are 41.75 & 3.62 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bafna Pharmaceuticals is 713.48 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bafna Pharmaceuticals share price is 318.50 & 94.77. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bafna Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in BAFNAPH
